{"id":22054,"date":"2024-08-01T17:12:44","date_gmt":"2024-08-01T22:12:44","guid":{"rendered":"https:\/\/medschool.prd.vanderbilt.edu\/career-development\/?p=22054"},"modified":"2024-08-02T14:20:37","modified_gmt":"2024-08-02T19:20:37","slug":"job-opportunity-research-analyst-clinical-accelerator-and-venture-fund-cancer-research-institute","status":"publish","type":"post","link":"https:\/\/medschool.vanderbilt.edu\/career-development\/2024\/08\/01\/job-opportunity-research-analyst-clinical-accelerator-and-venture-fund-cancer-research-institute\/","title":{"rendered":"Job Opportunity: Research Analyst, Clinical Accelerator and Venture Fund, Cancer Research Institute, New York, NY"},"content":{"rendered":"

The Organization<\/strong>
\nThe Cancer Research Institute (CRI), established in 1953 and headquartered in New York
\nCity, is the preeminent U.S. nonprofit organization dedicated to saving more lives by
\nfueling the discovery and development of powerful immunotherapies for all cancers.
\nGuided by a world-renowned Scientific Advisory Council that includes four Nobel
\nlaureates and 35 members of the National Academy of Sciences, CRI has invested over
\n$517 million in support of research conducted by immunologists and tumor immunologists
\nat the world\u2019s leading medical centers and universities and has contributed to many of the
\nkey scientific advances that demonstrate the potential for immunotherapy to change the
\nface of cancer treatment. The Cancer Research Institute\u2019s research funding supports the
\nentire continuum of basic discovery through early-stage clinical development of
\nnovel cancer immunotherapies.<\/p>\n

The Opportunity: Research Analyst, Clinical Accelerator and Venture<\/strong>
\nFund<\/strong>
\nThe role offers this high-performing individual the opportunity to work in a wellcapitalized
\nnonprofit organization and to lead work that will have a direct impact on the
\ndevelopment of potentially curative treatments for all types of cancer. The Research
\nAnalyst will be able to collaborate with CRI\u2019s scientific leadership as well as
\npharmaceutical, biotechnology, clinical trial management partners, and venture capital
\ninvestors. The individual will also be able to stay on top of key immunotherapy trends
\nand developments in oncology.<\/p>\n

The Research Analyst will be an integral team member of one of CRI\u2019s flagship
\nprograms, the Clinical Accelerator, a unique nonprofit-academia-industry collaboration
\nmodel that serves as a synergistic \u201cincubator\u201d for multi-center clinical trials testing
\npromising new cancer immunotherapy combinations in areas of high unmet medical
\nneed. CRI partners with leading clinician\/researchers, biopharmaceutical companies,
\nand nonprofit partners to develop new study concepts and conduct such studies. The
\nClinical Accelerator team leads the entire process, including sourcing new study ideas,
\nbusiness development-related activities including sourcing new drugs and study
\nfunding, design of the clinical study and translational research plans, execution\/oversite
\nof the clinical trial, and driving the publication strategy. The program provides
\nphilanthropic investment and clinical resources to accelerate the clinical development of
\nCRI-supported clinical studies. The Clinical Accelerator team is also responsible for
\nleading and managing CRI\u2019s venture investment practice, including souring new
\nopportunities, conducting due diligence, liaising with existing and potential investors,
\nand managing the CRI investment portfolio.<\/p>\n

Working closely with the Clinical Accelerator\u2019s leadership, the successful candidate will
\nbe an integral part of the program\u2019s scientific diligence efforts, including:
\n\u2022 Reviewing and evaluating scientific posters, publications, websites, and
\nconfidential preclinical\/clinical data from pharmaceutical and biotechnology
\ncompanies;
\n\u2022 Liaising with CROs, clinical teams, and company partners to review and select
\nnovel drug combinations to be tested in CRI clinical trials;
\n\u2022 Monitoring and assisting in coordinating clinical trial design and
\ncorrelative research strategies of CRI clinical trials;
\n\u2022 Monitoring the immune-oncology drug development competitive landscape to
\ngenerate new, field-wide analyses that will help guide the evolution of CRI\u2019s
\noverall program strategies;
\n\u2022 Updating the Clinical Accelerator\u2019s IO landscape database and leading
\npublication of the update;
\n\u2022 Collaborating with team members and partners on the publication of additional
\nresearch in leading academic or trade journals;
\n\u2022 Assisting in completing ad hoc consulting assignments;
\n\u2022 Attending and reporting on scientific\/industry conferences, i.e. ASCO, AACR, and
\nSITC, and medical meetings; and
\n\u2022 Assisting with the due diligence and evaluation on new venture investing
\nopportunities as well as monitoring CRI\u2019s venture investment portfolio.
\n
\nProfessional Experience<\/strong>
\n\u2022 An advanced technical degree (Ph.D., M.D., or equivalent) in
\nimmunology, cancer immunotherapy or relevant cancer research field is required;
\n\u2022 2+ years of postdoctoral or industry experience in cancer immunology or
\nimmuno-oncology is highly preferred;
\n\u2022 An advanced, deep, and current understanding of the basic and clinical science
\nof cancer immunology, exemplified by outstanding publications;
\n\u2022 Strong analytical skills, e.g., excellence in self-guided research, proficiency in
\nstatistics, skillful in Excel, PowerPoint, and other equivalent data analytical tools
\nor software;
\n\u2022 Experience with data science (e.g., Python, R, SQL, or equivalent) is highly
\ndesired;
\n\u2022 Strong interpersonal skills and ability to work effectively either in a team or
\nindependently;
\n\u2022 A high degree of proven written and verbal communication skills; and
\n\u2022 Must be comfortable in a hands-on, self-guided, and self-started work
\nenvironment:
\no Must be able to work effectively with timelines and high workloads (time
\nmanagement), and have a level of sophistication that would be typical
\nof research analyst\/healthcare consulting roles in for-profit companies in
\nhealthcare industry;
\no Previous exposure to clinical drug development, clinical studies and
\nregulatory affairs is a plus but not required; and
\no Previous exposure to life science diligence, investments and intellectual
\nproperty is a plus, but not required.<\/p>\n

Personal Characteristics<\/strong>
\n\u2022 Motivated by CRI\u2019s mission to turn cancer into a curable disease;
\n\u2022 Thrive in a collaborative team environment;
\n\u2022 Desire to learn and comfortable asking questions, solving complex problems
\nproactively and autonomously;
\n\u2022 The highest standard of professionalism;
\n\u2022 High work integrity with attention to details;
\n\u2022 A collaborative, personable, and adaptable personality; and
\n\u2022 Comfortable working regularly with off-site colleagues\/clients over email, phone,
\nor other remote technologies.<\/p>\n

Compensation<\/strong>
\nCancer Research Institute is prepared to offer the successful candidate a competitive
\ncompensation package that includes a base salary of between $95,000 \u2013 $115,000,
\ncomprehensive health insurance, generous retirement benefits, and potential for
\nperformance-based bonuses, similar to those of for-profit organizations.<\/p>\n

Work Location<\/strong>
\nCurrent work policy requires staff to be in the office in lower Manhattan every
\nWednesday and ability to work remotely Monday, Tuesday, Thursday, and Friday.<\/p>\n

Contact<\/strong>
\nPlease send cover letter and resume to:
\nJay Campbell
\nManaging Director, Clinical Accelerator and Venture Fund
\nCancer Research Institute
\n29 Broadway, Floor 4
\nNew York, NY 10006
\njcampbell@cancerresearch.org<\/p>\n

Printable job description: CRI-Research-Analyst-Clinical-Accelerator-and-Venture-Fund<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

The Organization The Cancer Research Institute (CRI), established in 1953 and headquartered in New York City, is the preeminent U.S. nonprofit organization dedicated to saving more lives by fueling the discovery and development of powerful immunotherapies for all cancers. Guided by a world-renowned Scientific Advisory Council that includes four Nobel laureates and 35 members of…<\/p>\n","protected":false},"author":20,"featured_media":21022,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[98,100],"tags":[24,33,69,234,11],"class_list":["post-22054","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-announcements","category-job-opportunities","tag-career-options-business-development","tag-career-options-entrepreneurship","tag-career-options-nonprofit-administration-management","tag-hybrid","tag-job-posting-non-faculty"],"acf":[],"jetpack_featured_media_url":"https:\/\/cdn.vanderbilt.edu\/t2-main\/medschool-prd\/wp-content\/uploads\/sites\/5\/2023\/12\/Jobs.png","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/medschool.vanderbilt.edu\/career-development\/wp-json\/wp\/v2\/posts\/22054","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medschool.vanderbilt.edu\/career-development\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medschool.vanderbilt.edu\/career-development\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medschool.vanderbilt.edu\/career-development\/wp-json\/wp\/v2\/users\/20"}],"replies":[{"embeddable":true,"href":"https:\/\/medschool.vanderbilt.edu\/career-development\/wp-json\/wp\/v2\/comments?post=22054"}],"version-history":[{"count":3,"href":"https:\/\/medschool.vanderbilt.edu\/career-development\/wp-json\/wp\/v2\/posts\/22054\/revisions"}],"predecessor-version":[{"id":22058,"href":"https:\/\/medschool.vanderbilt.edu\/career-development\/wp-json\/wp\/v2\/posts\/22054\/revisions\/22058"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medschool.vanderbilt.edu\/career-development\/wp-json\/wp\/v2\/media\/21022"}],"wp:attachment":[{"href":"https:\/\/medschool.vanderbilt.edu\/career-development\/wp-json\/wp\/v2\/media?parent=22054"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medschool.vanderbilt.edu\/career-development\/wp-json\/wp\/v2\/categories?post=22054"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medschool.vanderbilt.edu\/career-development\/wp-json\/wp\/v2\/tags?post=22054"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}